Colorectal cancer (CRC) still afflicts a large number of patients worldwide and is the third most common cancer diagnosed in Western countries as well as the third most common cause of cancer deaths. Colonoscopy is the gold standard for CRC diagnosis but is unsuitable for mass screening, while fecal immunochemical testing (FIT) for occult blood in the feces suffers from low specificity (particularly for polyps) and insufficient patient compliance. Recent studies using a metabolomic approach with gas chromatography-mass spectrometry (GC–MS) analysis of the exhaled breath of these patients have demonstrated the occurrence of significant changes in the pattern of their volatile organic compounds (VOCs) compared to healthy controls. Therefore, detection of an altered pattern of VOCs has been proposed as a potential screening tool in CRC [1]. However, the identification and analysis of these molecules by GC/MS is complex and time consuming. Several commercial and/or custom electronic noses (e-nose) that try to reproduce human senses using sensor arrays and systems have been developed and are currently used in several research fields including medicine. The aim of this study was to test the reliability of a commercial e-nose as screening tool for patients with CRC and polyps.

The use of the PEN3 e-nose in the screening of colorectal cancer and polyps

Altomare, D. F;Picciariello, A.;Caputi Iambrenghi, O.;Ugenti, I.;Guglielmi, A. G.;De Gennaro, G.
2016-01-01

Abstract

Colorectal cancer (CRC) still afflicts a large number of patients worldwide and is the third most common cancer diagnosed in Western countries as well as the third most common cause of cancer deaths. Colonoscopy is the gold standard for CRC diagnosis but is unsuitable for mass screening, while fecal immunochemical testing (FIT) for occult blood in the feces suffers from low specificity (particularly for polyps) and insufficient patient compliance. Recent studies using a metabolomic approach with gas chromatography-mass spectrometry (GC–MS) analysis of the exhaled breath of these patients have demonstrated the occurrence of significant changes in the pattern of their volatile organic compounds (VOCs) compared to healthy controls. Therefore, detection of an altered pattern of VOCs has been proposed as a potential screening tool in CRC [1]. However, the identification and analysis of these molecules by GC/MS is complex and time consuming. Several commercial and/or custom electronic noses (e-nose) that try to reproduce human senses using sensor arrays and systems have been developed and are currently used in several research fields including medicine. The aim of this study was to test the reliability of a commercial e-nose as screening tool for patients with CRC and polyps.
File in questo prodotto:
File Dimensione Formato  
The use of the PEN3 e-nose in the screening of colorectal cancer_2016.pdf

non disponibili

Descrizione: articolo principale
Tipologia: Documento in Versione Editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 623.86 kB
Formato Adobe PDF
623.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/171537
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
social impact